How we treat: patients with haemophilia undergoing screening colonoscopy.
Fogarty
P F
PF
Hematology/Oncology Division, University of California, San Francisco, San Francisco, CA 94143-1270, USA. pfogarty@medicine.ucsf.edu
Kouides
P
P
D015119:Aminocaproic Acid / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D003113:Colonoscopy; D005164:Factor IX / Q000627:therapeutic use*; D006467:Hemophilia A / Q000150:complications*; D002836:Hemophilia B / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011127:Polyps / Q000175:diagnosis / Q000601:surgery*; D019106:Postoperative Hemorrhage / Q000517:prevention & control*; D011292:Premedication; D011994:Recombinant Proteins / Q000627:therapeutic use; D016896:Treatment Outcome
D000933:Antifibrinolytic Agents; D011994:Recombinant Proteins; D005164:Factor IX; D015119:Aminocaproic Acid